Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis.

Chandan VangalaJingbo NiuColin R LenihanWilliam E MitchSankar D NavaneethanWolfgang C Winkelmayer

Published in: Clinical journal of the American Society of Nephrology : CJASN (2018)

Among patients with ESKD on hemodialysis, PPIs and not histamine-2 receptor antagonists were associated with hip fracture events.

Keyphrases